A bill to direct the Secretary of Veterans Affairs to establish a precision oncology program for cancer of the prostate at the Department of Veterans Affairs, and for other purposes.
About This Bill
Committee
Latest Action · July 15, 2026
Read twice and referred to the Committee on Veterans' Affairs.
The POPCaP Act of 2026 directs the Department of Veterans Affairs to establish a nationwide precision oncology program focused on prostate cancer treatment for veterans. The program will designate 28 VA medical centers as "centers of excellence" across the country, with at least one center in each regional VA network, and requires the VA to maintain a minimum of 21 operating centers at all times. Each center must employ a multidisciplinary team including medical oncologists, urologists, radiation oncologists, pathologists, and research staff, and will conduct genetic sequencing, develop biomarker-specific clinical trials, participate in telemedicine tumor boards, and maintain a prostate cancer registry. A Program Leadership team based at the Seattle VA Medical Center will coordinate nationwide efforts, oversee clinical trials, and manage industry partnerships. The VA must establish the program by January 1, 2027, submit an implementation plan within 180 days, and provide annual reports to Congress beginning in 2028, with $15.5 million authorized for each fiscal year from 2027 through 2029.
Take Action
Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.